Skip to main content

User account menu

  • Contact Us
  • Log in
Home

Main navigation

  • Home
  • Centers
  • Research Cores
  • Publications
  • Meetings
  • News
  • Funding Opportunity
  • Diabetes Resources
  • Pilot & Feasibility
  • NIDDK Centers
    • Diabetes Translation
    • Cystic Fibrosis Translation
    • Mouse Metabolic Phenotyping
    • Nutrition Obesity

After Tirzepatide: What happens to body composition and metabolic health?

Debra L Safer MD
Stanford University
2024 Pilot & Feasibility Awardee
Email
Center Stanford University
Award Year 2024
Pilot Study After Tirzepatide: What happens to body composition and metabolic health?
Awardee Debra L Safer MD ORCiD
Supported by grant Diabetes Research Centers (P30) from the National Institute of Diabetes and Digestive and Kidney Diseases